Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual...
Saved in:
Published in | Clinical ophthalmology (Auckland, N.Z.) Vol. 9; no. default; pp. 1373 - 1378 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2015
Taylor & Francis Ltd Dove Press Dove Medical Press |
Subjects | |
Online Access | Get full text |
ISSN | 1177-5483 1177-5467 1177-5483 |
DOI | 10.2147/OPTH.S86450 |
Cover
Loading…
Abstract | To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients.
The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed.
A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05).
Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. |
---|---|
AbstractList | Purpose: To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. Patients and methods: The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed. Results: A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05). Conclusion: Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. Keywords: primary open-angle glaucoma, normal-tension glaucoma, intraocular pressure, progression of visual field defects, MD slope Tomoko Naito,1 Keiji Yoshikawa,2 Shiro Mizoue,3 Mami Nanno,4 Tairo Kimura,5 HirotakaSuzumura,6 Fumio Shiraga1 1Department of Ophthalmology, Okayama University Graduate School of Medicine, Okayama, Japan; 2Yoshikawa Eye Clinic, Tokyo, Japan; 3Department of Ophthalmology, Ehime University Graduate School ofMedicine, Ehime, Japan; 4Kagurazaka Minamino Eye Clinic, 5Ueno Eye Clinic, 6Suzumura Eye Clinic, Tokyo,Japan Purpose: To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients.Patients and methods: The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed.Results: A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05).Conclusion: Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. Keywords: primary open-angle glaucoma, normal-tension glaucoma, intraocular pressure, progression of visual field defects, MD slope To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients.Patients and methods: The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed.Results: A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05).Conclusion: Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed. A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05). Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. PURPOSETo analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients.PATIENTS AND METHODSThe subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed.RESULTSA total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05).CONCLUSIONReducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. Purpose: To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. Patients and methods: The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed. Results: A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05). Conclusion: Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. |
Audience | Academic |
Author | Yoshikawa, Keiji Suzumura, Hirotaka Mizoue, Shiro Kimura, Tairo Shiraga, Fumio Naito, Tomoko Nanno, Mami |
AuthorAffiliation | 1 Department of Ophthalmology, Okayama University Graduate School of Medicine, Okayama, Japan 4 Kagurazaka Minamino Eye Clinic, Tokyo, Japan 5 Ueno Eye Clinic, Tokyo, Japan 6 Suzumura Eye Clinic, Tokyo, Japan 2 Yoshikawa Eye Clinic, Tokyo, Japan 3 Department of Ophthalmology, Ehime University Graduate School of Medicine, Ehime, Japan |
AuthorAffiliation_xml | – name: 1 Department of Ophthalmology, Okayama University Graduate School of Medicine, Okayama, Japan – name: 6 Suzumura Eye Clinic, Tokyo, Japan – name: 4 Kagurazaka Minamino Eye Clinic, Tokyo, Japan – name: 3 Department of Ophthalmology, Ehime University Graduate School of Medicine, Ehime, Japan – name: 2 Yoshikawa Eye Clinic, Tokyo, Japan – name: 5 Ueno Eye Clinic, Tokyo, Japan |
Author_xml | – sequence: 1 givenname: Tomoko surname: Naito fullname: Naito, Tomoko – sequence: 2 givenname: Keiji surname: Yoshikawa fullname: Yoshikawa, Keiji – sequence: 3 givenname: Shiro surname: Mizoue fullname: Mizoue, Shiro – sequence: 4 givenname: Mami surname: Nanno fullname: Nanno, Mami – sequence: 5 givenname: Tairo surname: Kimura fullname: Kimura, Tairo – sequence: 6 givenname: Hirotaka surname: Suzumura fullname: Suzumura, Hirotaka – sequence: 7 givenname: Fumio surname: Shiraga fullname: Shiraga, Fumio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26229431$$D View this record in MEDLINE/PubMed |
BookMark | eNptkttrFDEUxgep2Is--S4Dggiya-4z81IoRW2hUNH6HDLJyWyW7GRNZlb8783e6m4peUg4-Z0vJx_feXHShx6K4i1GU4JZ9fn--8PN9GctGEcvijOMq2rCWU1PDs6nxXlKc4QEQXX1qjglgpCGUXxWhB_g1eBCn2ZuWbYw_AHoy2UMXYSUcr0Mtly5NCpfWgfelAYs6KFUvSldP0QV9OhVzC2ZHyPkYj67hYp_y7CEfqL6zkPZeTXqsFCvi5dW-QRvdvtF8evrl4frm8nd_bfb66u7iRY1GibCKF3VgoAgRllsDK84RUY0DYYWcyMUWMZrQjkV2IgKaYUro2mjW0uMqelFcbvVNUHN5W4gGZSTm0KInVRxcNqDrOsWNy3GiCrBiG0VAcivKmGpoDVustblVms5tgswGtbf9keixze9m8kurCTjWOBKZAG0H2YFG6OeTLSvZockIRVft3zcvRnD7xHSIBcuafBe9RDGJHGFMGWMbdTfP0HnYYx9djdrEU5JnU36T3Uq_9n1NuRR9VpUXjHGKyoEZ5maPkPlZWDhdM6ddbl-1PDhoGEGyg-zFPy4idQx-O7QxEcD9lHMwKctoGNIKYJ9RDCS66DLddDlNuiZxk9o7YZNkPPAzj_b8w9FtgFN |
CitedBy_id | crossref_primary_10_1111_ceo_13372 crossref_primary_10_1136_bmjopen_2017_019416 crossref_primary_10_1371_journal_pone_0164876 crossref_primary_10_1007_s12325_017_0552_5 crossref_primary_10_1111_jcpt_12468 crossref_primary_10_1038_s41598_021_87844_1 crossref_primary_10_1167_iovs_18_24635 crossref_primary_10_1007_s00347_018_0658_4 crossref_primary_10_1155_2017_1480746 crossref_primary_10_1007_s12325_016_0297_6 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2015 Dove Medical Press Limited 2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2015 Naito et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 |
Copyright_xml | – notice: COPYRIGHT 2015 Dove Medical Press Limited – notice: 2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2015 Naito et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8AO 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M2O MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.2147/OPTH.S86450 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1177-5483 |
EndPage | 1378 |
ExternalDocumentID | oai_doaj_org_article_88b19b1103a642fba2ee2daa6f363819 PMC4516176 oai_dovepress_com_22756 A445736654 26229431 10_2147_OPTH_S86450 |
Genre | Journal Article |
GeographicLocations | Blue Mountains United States--US Japan |
GeographicLocations_xml | – name: United States--US – name: Blue Mountains – name: Japan |
GroupedDBID | --- 0YH 29B 2WC 53G 5VS 6J9 7X7 8AO 8FI 8FJ 8G5 AAYXX ABDBF ABUWG ACGFO ACUHS ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI C1A CCPQU CITATION DIK DWQXO E3Z EBD EBS EJD F5P FRP FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR IHW ITC KQ8 M2O M48 O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM TDBHL TR2 UKHRP VDV W2D NPM PMFND 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO - ADACO BBAFP LI0 M~E 5PM |
ID | FETCH-LOGICAL-c680t-6dac7862e62daf1dd57530d6991eb15d6aef458235361d670ca17dc39cbf2dd83 |
IEDL.DBID | M48 |
ISSN | 1177-5483 1177-5467 |
IngestDate | Wed Aug 27 01:30:06 EDT 2025 Thu Aug 21 14:13:20 EDT 2025 Mon Jan 18 10:57:23 EST 2021 Fri Sep 05 09:08:05 EDT 2025 Mon Jun 30 06:30:43 EDT 2025 Tue Jun 17 21:32:36 EDT 2025 Tue Jun 10 20:21:59 EDT 2025 Thu May 22 21:12:46 EDT 2025 Mon Jul 21 06:02:00 EDT 2025 Thu Apr 24 23:12:54 EDT 2025 Tue Jul 01 02:21:33 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | default |
Keywords | normal-tension glaucoma progression of visual field defects intraocular pressure primary open-angle glaucoma MD slope |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c680t-6dac7862e62daf1dd57530d6991eb15d6aef458235361d670ca17dc39cbf2dd83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/opth.s86450 |
PMID | 26229431 |
PQID | 2225328536 |
PQPubID | 3933183 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_88b19b1103a642fba2ee2daa6f363819 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4516176 dovepress_primary_oai_dovepress_com_22756 proquest_miscellaneous_1701344476 proquest_journals_2225328536 gale_infotracmisc_A445736654 gale_infotracacademiconefile_A445736654 gale_healthsolutions_A445736654 pubmed_primary_26229431 crossref_primary_10_2147_OPTH_S86450 crossref_citationtrail_10_2147_OPTH_S86450 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-01-01 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand – name: Auckland |
PublicationTitle | Clinical ophthalmology (Auckland, N.Z.) |
PublicationTitleAlternate | Clin Ophthalmol |
PublicationYear | 2015 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Press Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove Press – name: Dove Medical Press |
References | 1168023 - Am J Ophthalmol. 1975 Apr;79(4):557-66 17698763 - Arch Ophthalmol. 2007 Aug;125(8):1124-5 12523884 - Arch Ophthalmol. 2003 Jan;121(1):48-56 19492005 - Can J Ophthalmol. 2009;44 Suppl 1:S7-93 11447046 - Am J Epidemiol. 2001 Jul 15;154(2):138-44 12049574 - Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30 21600658 - Ophthalmology. 2011 Sep;118(9):1766-73 15350316 - Ophthalmology. 2004 Sep;111(9):1641-8 10844054 - Am J Ophthalmol. 2000 May;129(5):623-8 9780093 - Am J Ophthalmol. 1998 Oct;126(4):487-97 17936908 - Ophthalmology. 2008 Jun;115(6):934-40 9780094 - Am J Ophthalmol. 1998 Oct;126(4):498-505 22352070 - Nippon Ganka Gakkai Zasshi. 2012 Jan;116(1):3-46 7081360 - Am J Ophthalmol. 1982 May;93(5):622-8 22551324 - Acta Ophthalmol. 2012 Aug;90(5):e337-43 19668554 - Clin Ophthalmol. 2009;3:117-22 14716185 - Menopause. 2004 Jan-Feb;11(1):69-77 11024415 - Am J Ophthalmol. 2000 Oct;130(4):429-40 2023748 - Ophthalmology. 1991 Mar;98(3):296-300 14609824 - Br J Ophthalmol. 2003 Nov;87(11):1324-8 18082889 - Ophthalmology. 2008 Jul;115(7):1123-1129.e3 1687295 - Trans Am Ophthalmol Soc. 1991;89:757-90 5437825 - Am J Ophthalmol. 1970 Apr;69(4):608-10 8058289 - Ophthalmology. 1994 Aug;101(8):1440-4 18695095 - Arch Ophthalmol. 2008 Aug;126(8):1030-6 15745761 - Ophthalmology. 2005 Mar;112(3):366-75 3390051 - Arch Ophthalmol. 1988 Jul;106(7):898-900 15037889 - Eye (Lond). 2004 Oct;18(10):984-9 16111758 - Ophthalmology. 2005 Oct;112(10):1661-9 9097306 - Ophthalmologica. 1997;211(2):66-71 11384564 - Am J Ophthalmol. 2001 Jun;131(6):699-708 12365904 - Arch Ophthalmol. 2002 Oct;120(10):1268-79 |
References_xml | – reference: 22551324 - Acta Ophthalmol. 2012 Aug;90(5):e337-43 – reference: 16111758 - Ophthalmology. 2005 Oct;112(10):1661-9 – reference: 15037889 - Eye (Lond). 2004 Oct;18(10):984-9 – reference: 12049574 - Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30 – reference: 12523884 - Arch Ophthalmol. 2003 Jan;121(1):48-56 – reference: 11384564 - Am J Ophthalmol. 2001 Jun;131(6):699-708 – reference: 1687295 - Trans Am Ophthalmol Soc. 1991;89:757-90 – reference: 2023748 - Ophthalmology. 1991 Mar;98(3):296-300 – reference: 9780094 - Am J Ophthalmol. 1998 Oct;126(4):498-505 – reference: 10844054 - Am J Ophthalmol. 2000 May;129(5):623-8 – reference: 22352070 - Nippon Ganka Gakkai Zasshi. 2012 Jan;116(1):3-46 – reference: 1168023 - Am J Ophthalmol. 1975 Apr;79(4):557-66 – reference: 5437825 - Am J Ophthalmol. 1970 Apr;69(4):608-10 – reference: 11024415 - Am J Ophthalmol. 2000 Oct;130(4):429-40 – reference: 15350316 - Ophthalmology. 2004 Sep;111(9):1641-8 – reference: 18082889 - Ophthalmology. 2008 Jul;115(7):1123-1129.e3 – reference: 19668554 - Clin Ophthalmol. 2009;3:117-22 – reference: 9097306 - Ophthalmologica. 1997;211(2):66-71 – reference: 3390051 - Arch Ophthalmol. 1988 Jul;106(7):898-900 – reference: 19492005 - Can J Ophthalmol. 2009;44 Suppl 1:S7-93 – reference: 9780093 - Am J Ophthalmol. 1998 Oct;126(4):487-97 – reference: 18695095 - Arch Ophthalmol. 2008 Aug;126(8):1030-6 – reference: 17936908 - Ophthalmology. 2008 Jun;115(6):934-40 – reference: 15745761 - Ophthalmology. 2005 Mar;112(3):366-75 – reference: 12365904 - Arch Ophthalmol. 2002 Oct;120(10):1268-79 – reference: 21600658 - Ophthalmology. 2011 Sep;118(9):1766-73 – reference: 14716185 - Menopause. 2004 Jan-Feb;11(1):69-77 – reference: 11447046 - Am J Epidemiol. 2001 Jul 15;154(2):138-44 – reference: 8058289 - Ophthalmology. 1994 Aug;101(8):1440-4 – reference: 17698763 - Arch Ophthalmol. 2007 Aug;125(8):1124-5 – reference: 14609824 - Br J Ophthalmol. 2003 Nov;87(11):1324-8 – reference: 7081360 - Am J Ophthalmol. 1982 May;93(5):622-8 |
SSID | ssj0062087 |
Score | 2.1012998 |
Snippet | To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and... Purpose: To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma... PURPOSETo analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma... Tomoko Naito,1 Keiji Yoshikawa,2 Shiro Mizoue,3 Mami Nanno,4 Tairo Kimura,5 HirotakaSuzumura,6 Fumio Shiraga1 1Department of Ophthalmology, Okayama University... |
SourceID | doaj pubmedcentral dovepress proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1373 |
SubjectTerms | Analysis Care and treatment Collaboration Comparative analysis Defects Development and progression Field study Glaucoma Hypertension Intraocular pressure MD slope Measurement Myopia normal-tension glaucoma Open-angle glaucoma Original Research primary open-angle glaucoma progression of visual field defects Standard deviation Visual acuity |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlhz4Ope-6SVsVAqUFU1uSJe0xLQ1LoQ9oArkJyZKThWCX7Dq_PzOS1qzbQi-9GWnWtmZG81h_miHkMCjHOHjSUtqalaLufOl0AxvPVt62fOGCjQDZb3J5Kr6cNWc7rb4QE5bKAyfGfdDa1QsHTopbCJU7Z1kIzFsrOy4x20DrCz5vm0wlGyxZpXNbFVVCTM7TyTzsyQO56Ab0R0uBR-13fFEs2X-P3PHDdcKg_mmkd7zUHEG545KOH5D7OZakR2kND8mt0D8it7_mr-WPyTAh3S5Wv2hGZNGIyErVOOjQ0evVeoSbRCQb9QHRHdT2nq7wkUNEqdL4ouNVgEG4juUpKLbdKm1_fhkoROAjKK59Qk6PP598Wpa5wULZSl1tSgniUJDSBAkc7WrvIXbjlZcQM4IJb7y0ocPvarzhsvZSVa2tlQcJtq5j3mv-lOz1Qx-eE1oJ1alFsHVlIePUVkvpNK-DgohEu04U5P2W1abN1cexCcalgSwE5WK-_zhZmp9RLgU5nIjzqv5O9hFlNpFgpew4APpjsv6Yf-lPQd5NEv_tTttR4KBhWCa_IK9RI0w6ojrZBnMkRKM49nEuyNtIgdYBltfafMgBmIR1tmaUBzNK2NXtfHqrdSZblbXB3JwzCLDgTd5M0_hLRMr1YRjXBuvrcyGEAppnSUmnZTHJ2AIixoKomfrO1j2f6VcXseY49nOulXzxP1i-T-5C2NmkP7IOyN7magwvIbTbuFdxF98A7N1ONQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegk_h4QHwTGGCkSQikbInt2O4T2tCmCokxwSbtzXJiZ6s0JaNt9vdz57ihAcRbZV_S2PfhO_vnO0J2vCoZh5U0lTZnqchrl5a6AMWzmbMVn5beBoDssZydiS_nxXnccFtGWOXaJgZD7doK98j3MC7hDBYX-en6Z4pVo_B0NZbQuE22wATrYkK2Dg6PT76vbbFkmY7lVVRagE3ob-hhbZ69byens90fWgq8cr-xJoXU_ffJXdfe9FjUv431xmo1RlJuLE1HD8mD6FPS_V4IHpFbvnlM7nyNp-ZPSDsg3i7n1zQis2hAZvVZOWhb05v5soOXBEQbdR5RHtQ2js7xL9uAVqXhQ7uFh0b4HdJUUCy_ldrm4spT8MQ7mEz7lJwdHZ5-nqWx0EJaSZ2tUglsURDaeMmcrXPnwIfjmZPgO4IpL5y0vsbzNQ6znzupssrmygEnq7Jmzmn-jEyatvEvCM2EqtXU2zyzEHlqq6UsNc-9As9El7VIyMf1VJsqZiHHYhhXBqIR5ItBvpieLwnZGYjjqP5NdoA8G0gwY3ZoaBcXJiqg0brMpyU4O9xCyFWXlnkPo7Wy5hKj1oR8GDj-x5vWrTCDhmG6_IS8RYkw_VXVwUaYfSEKxbGec0LeBwq0EjC8ysbLDjBJmG9rRLk9ogTtrsbda6kz0boszW9dSMi7oRufRMRc49tuaTDPPhdCKKB53gvpMCwmGZuC55gQNRLf0bjHPc38MuQex7rOuZIv__9Zr8g9cCyLfqtqm0xWi86_BudtVb6JGvoLNc1GcA priority: 102 providerName: ProQuest |
Title | Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26229431 https://www.proquest.com/docview/2225328536 https://www.proquest.com/docview/1701344476 http://www.dovepress.com/getfile.php?fileID=26094 https://pubmed.ncbi.nlm.nih.gov/PMC4516176 https://doaj.org/article/88b19b1103a642fba2ee2daa6f363819 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3raxQxEA-1BR8fxLer9YxQEIWV3SSb5D6ItNJyCK1Fe3B-CtlNtj04dvUeRf97Z7IPurUf_XIcyewj80hmNr_MELLnVc44rKSxtCmLRVq6ONcZGJ5NnC34OPc2AGRP5GQqvsyy2RbpinG2DFzdGNphPanpcvHh968_n8DgPyKMORUK2tegEVoKjN13YEmSqN7Hot9OkCzRbZUVFYOLzpuDetcvHixNIYP_PXLH1ZcNJPXfOfvKojUEVF5ZoY4ekPuta0n3G114SLZ89YjcPm43zx-Tuge-Xcx_0hagRQNAq0nOQeuSXs5XG7hJALZR5xHsQW3l6BwfWQfQKg0vull6aIT_IVsFRa7FtjpfeAoO-Qb02D4h06PDs8-TuK23EBdSJ-tYgnQURDheMmfL1Dlw5XjiJLiQMKNnTlpf4jYbz7hMnVRJYVPlQKBFXjLnNH9Ktqu68s8JTYQq1djbNLEQgGqrpcw1T70CB0XnpYjI-47VpmiTkWNNjIWBoATlYr6enk3M9yCXiOz1xO2obiY7QJn1JJg4OzTUy3PT2qHROk_HOfg83ELkVeaWeQ-jtbLkEoPXiLzrJX7tTl0rcNAwzJofkdeoEaY5sdpPFWZfiExxLOsckbeBAtUXhlfY9swDMAnTbg0odweUYOTFsLvTOtPZiMFQnTPwt-BN3vTdeCUC5ypfb1YG0-1zIYQCmmeNkvbDYpKxMTiQEVED9R2Me9hTzS9CCnIs75wq-eJ_sPwluQteaNZ819ol2-vlxr8CT2-dj8it5McEftVMjcjOweHJ6bdR-GoyCvb9F4K6WeI |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VIlF4QNwECjVSEaJSaOIkdvYBoXJUW3qAxFbaN-PETrtSlZQ9ivhT_EZmnIMNIN76tnJmHdszniP-PAOwaWXGI7SkvtAh9-OwMH6WJrjxdGB0Hg0yqx1A9kgMj-OP42S8Aj_buzAEq2x1olPUpsrpG_k2xSURR-Mi3px_86lqFJ2utiU0arHYtz--Y8g2e733Hvn7nPPdD6N3Q7-pKuDnIg3mvsAxSPTjreBGF6Ex6LBEgRHoKKHeSozQtqDDpAhfFRohg1yH0uCw86zgxqQR9nsFrqLhDShXvxx3AZ7gQdoUc5F-ghqovg9IlYC2P30eDV99SUVMF_yXLKArFHAD1kx1USNf_zYNS7axj9tcMoS7t-Bm48GynVrkbsOKLe_AtcPmjP4uVB2-7nRyzhocGHM4sDoHCKsKdjGZLbATh59jxhKmhOnSsAm9snLYWOYGuphabMTfLikGo2Jfvi5PzixDv3-BrNP34PhSGHAfVsuqtA-BBbEs5MDqMNAY56Y6FSJLo9BK9IPSrIg92GqXWuVNznMqvXGmMPYhvijii6r54sFmR9zM6t9kb4lnHQnl53YN1fRENdtdpWkWDjJ0rSKNAV6RaW4tzlaLIhIUI3vwsuP4Hz21rbiCilNyfg82SCJUfTG200hqJ44TGVH1aA9eOArSSTi9XDdXK3CRKLtXj3K9R4m6JO8_bqVONbpspn7vPA-edY_pn4TPK221mCnK6h_FcSyR5kEtpN20uOB8gNvFA9kT3968-0_KyanLdE5VpEMpHv1_WBuwNhwdHqiDvaP9x3AdXdqk_ki2Dqvz6cI-Qbdxnj11e5XB18tWDr8AABKCfw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVipwQLwJFGqkIgRS2MRJbO8BoZZ2taWwVLSVejNO7LQrVUnZRxF_jV_HTOKEDSBuva2cWcfjsecRf54hZNOKlEVgSX2uQ-bHYW78VCaw8XRgdBYNUqsrgOyYj47jDyfJyQr52dyFQVhloxMrRW3KDL-R9zEuiRgYF97PHSziYGf47uKbjxWk8KS1KadRL5F9--M7hG-zt3s7IOsXjA13j96PfFdhwM-4DOY-h_EI8OktZ0bnoTHgvESB4eA0gQ5LDNc2x4OlCF4bGi6CTIfCAAtZmjNjZAT9XiOrAqyi7JHV7d3xwZfGDnAWSFfaRfgJ6KP6diDWBep_PjgavTmUPMbr_kv2sCobcJNcN-VljYP921AsWcouinPJLA5vk1vOn6Vb9QK8Q1ZscZesfXIn9vdI2aLtziYX1KHCaIUKqzOC0DKnl5PZAjqp0HTUWESYUF0YOsFXlhVSllYDXUwtNMLvKkUGxdJfvi5Ozy2FKGABgtT3yfGViOAB6RVlYR8RGsQiFwOrw0BD1Cu15DyVUWgFeEUyzWOPvG6mWmUuAzoW4jhXEAmhXBTKRdVy8chmS-y4-jfZNsqsJcFs3VVDOT1VbvMrKdNwkIKjFWkI9_JUM2uBW83ziGPE7JFXrcT_6KlphRlUDFP1e2QDV4Sqr8m2-kltxXEiIqwl7ZGXFQVqKGAv0-6iBUwS5vrqUK53KEGzZN3HzapTTrPN1O996JHn7WP8J6L1ClsuZgpz_EdxHAugeVgv0pYtxhkbgNfqEdFZvh2-u0-KyVmV9xxrSoeCP_7_sDbIGigG9XFvvP-E3AD_Nqm_mK2T3ny6sE_Bh5ynz9xmpeTrVeuHX6faiCM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+progression+of+visual+field+defect+and+intraocular+pressure+in+primary+open-angle+glaucoma&rft.jtitle=Clinical+ophthalmology+%28Auckland%2C+N.Z.%29&rft.au=Naito+T&rft.au=Yoshikawa+K&rft.au=Mizoue+S&rft.au=Nanno+M&rft.date=2015-01-01&rft.pub=Dove+Medical+Press&rft.issn=1177-5483&rft.volume=2015&rft.issue=default&rft.spage=1373&rft.epage=1378&rft_id=info:doi/10.2147%2Fopth.s86450&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_88b19b1103a642fba2ee2daa6f363819 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1177-5483&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1177-5483&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1177-5483&client=summon |